Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Elite Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 82.0K | +82.0K |
| Value | $0 | $2.38K | +$2.38K |
New holders (1)
Institutions that held Elite Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fisher Asset Management, LLC | 82,000 | $2.38K | 0.00% |
Sold out (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.
None.